What are the inclusion criteria for the Bollano ANZ Carvedilol study?
The inclusion criteria for the Bollano ANZ Carvedilol study are chronic stable heart failure due to ischaemic heart disease (defined as a documented history of myocardial infarction, typical angina, an exercise electrocardiogram positive for ischaemia, or angiographic evidence of coronary disease), LVEF by radionuclide ventriculography of less current NYHA class II or III, or previous class II-IV current NYHA class IV heart rate below 50 bpm; sick sinus syndrome; second degree or third- degree heart block; blood pressure below 90 mmHg systolic or above 160/100 mm Hg; and treadmill exercise duration less than 2 min or more than 18 min (modified Naughton protocol). 